Stimpson Jim P, Liao Joshua M, Morenz Anna M, Joo Joseph H, Wilson Fernando A
Department of Health Economics, Systems, and Policy, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Cancer. 2025 May 15;131(10):e35904. doi: 10.1002/cncr.35904.
Colorectal cancer (CRC) screening disparities persist among populations with limited health care access. Although Medicaid expansion and paid sick leave could address these barriers, there is limited data on the combined impact of these policies and CRC screening.
The authors conducted a difference-in-differences analysis using 2012-2018 Behavioral Risk Factor Surveillance System data. The study population included adults 50-75 years of age meeting preventive cancer screening guidelines during the study period. States were categorized into three groups: those with Medicaid expansion and paid sick leave (ME + SL), Medicaid expansion without paid sick leave (MEnoSL), and neither policy (NoME/NoSL). The pre-policy period was 2012-2014 and the post-policy period was 2015-2018. The outcome was the percent up-to-date with CRC screening. Survey-weighted logistic regression models accounted for individual- and state-level covariates and state-clustered standard errors.
Post-policy implementation, CRC up-to-date screening was 2.9 percentage points greater in ME + SL states compared to MEnoSL states (p < .001) and 4.2 percentage points greater compared to NoME/NoSL states (p = .018). These changes correspond to an estimated 352,343 and 1,087,140 fewer missed screenings between ME + SL and MEnoSL and NoME/NoSL states, respectively. The increased percent of up-to-date CRC screenings was associated with a reduction in colorectal cancer deaths: 8456 from ME + SL versus MEnoSL and 26,091 from ME + SL versus NoME/NoSL.
Medicaid expansion combined with paid sick leave was associated with a greater likelihood of being up-to-date with CRC screening compared to Medicaid expansion alone or neither policy.
在医疗保健机会有限的人群中,结直肠癌(CRC)筛查差异持续存在。尽管医疗补助扩大和带薪病假可以消除这些障碍,但关于这些政策与CRC筛查综合影响的数据有限。
作者使用2012 - 2018年行为风险因素监测系统数据进行了双重差分分析。研究人群包括在研究期间符合预防性癌症筛查指南的50 - 75岁成年人。各州分为三组:有医疗补助扩大和带薪病假的州(ME + SL)、有医疗补助扩大但无带薪病假的州(MEnoSL)以及两种政策都没有的州(NoME/NoSL)。政策实施前时期为2012 - 2014年,政策实施后时期为2015 - 2018年。结果是CRC筛查最新的百分比。调查加权逻辑回归模型考虑了个体和州层面的协变量以及州聚类标准误差。
政策实施后,与MEnoSL州相比,ME + SL州的CRC最新筛查率高2.9个百分点(p <.001),与NoME/NoSL州相比高4.2个百分点(p =.018)。这些变化分别对应于ME + SL与MEnoSL州以及ME + SL与NoME/NoSL州之间估计少错过352,343次和1,087,140次筛查。CRC最新筛查百分比的增加与结直肠癌死亡人数的减少相关:ME + SL与MEnoSL州相比减少8456例,ME + SL与NoME/NoSL州相比减少26,091例。
与单独的医疗补助扩大或两种政策都没有相比,医疗补助扩大与带薪病假相结合与更有可能进行CRC最新筛查相关。